2014
DOI: 10.1007/s00044-014-1093-y
|View full text |Cite
|
Sign up to set email alerts
|

Pentacyclic triterpenoids from Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Shum: in vitro cytotoxic and leishmanicidal and in vivo anti-inflammatory and antioxidative activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 55 publications
0
3
0
Order By: Relevance
“…For example, lupeol was found to have anti-cancer and anti-inflammatory properties [Saleem, 2009]. Methyl ursolate displayed in vitro cytotoxic and leishmanicidal activities, while in vivo anti-inflammatory and antioxidative abilities [Fabri et al, 2014]. Lupeol acetate showed to slow down the progression of rheumatoid arthritis by inhibiting the activation of macrophages and osteoclastogenesis [Wang et al, 2016].…”
Section: Resultsmentioning
confidence: 99%
“…For example, lupeol was found to have anti-cancer and anti-inflammatory properties [Saleem, 2009]. Methyl ursolate displayed in vitro cytotoxic and leishmanicidal activities, while in vivo anti-inflammatory and antioxidative abilities [Fabri et al, 2014]. Lupeol acetate showed to slow down the progression of rheumatoid arthritis by inhibiting the activation of macrophages and osteoclastogenesis [Wang et al, 2016].…”
Section: Resultsmentioning
confidence: 99%
“…195 On testing their in vitro antileishmanial activity against amastigote form of L. major, the pentacyclic triterpenoids ursolic acid (103) and Me ursolate (104) obtained from the aerial parts of the plant Mitracarpus frigidus, were found to possess IC 50 values of 0.28 mM and 0.45 mM, respectively. 196 Compound (105), a nor-triterpene isolated from Lophanthera lactescens, showed antileishmanial activity against amastigote form of L. amazonensis with IC 50 value of 0.50 mM. 197 6.1.5.…”
Section: Brief Summary Of Promising Scaffoldsmentioning
confidence: 99%
“…The seriousness of the disease prompted several research groups to work on the development of new antileishmanial agents and the class of scaffolds explored includes various quinolines, [10–13] chalcones, [14,15] nitroimidazole, [16] triazolopyrimidine, [17] pyrazolopyrimidine, [18,19] aminopyrazole, [20] triazine, [21,22] quinazoline, [23] thymidine, [24] triterpenoids, [25] and quinazolinone [26] . The isolation and synthesis of a new class of biaryl naphthylisoquinoline alkaloid ancistroealaine A ( 1a ) from Ancistrocladus ealaensis and other alkaloids ( 1b , 1c ), and their antileishmanial activity has generated interest in the development of new antileishmanial agents [27–29] .…”
Section: Introductionmentioning
confidence: 99%